SCHEMBL5320960

SCHEMBL5320960

COC(=O)C(C(=O)C1CCCCC1)c1c(F)cc(F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CTSB P07858 2/20 0.37
SLC6A3 Q01959 2/20 0.36
RIPK1 Q13546 1/20 0.36
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
GAA P10253 1/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
ALDH1A1 P00352 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SLC6A9 P48067 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1477269 0.89 ALDH1A1 (0.39) CTSBSLC6A3RIPK1CASP3SENP8
SCHEMBL3686370 0.80 MAPK1 (0.36) SLC6A3GAANPC1POLBRAB9A
SCHEMBL156999 0.76 MAPK1 (0.34) SLC6A3GAANPC1POLBRAB9A
SCHEMBL4707996 0.70 SLC6A3 (0.52) SLC6A3ALDH1A1
SCHEMBL21765808 0.68 CES2 (0.41) SLC6A3ALDH1A1NPSR1SMN1; SMN2
SCHEMBL1477896 0.67 MAPT (0.39) GAANPC1POLBRAB9AALDH1A1
SCHEMBL3091676 0.65 SMN1; SMN2 (0.39) SLC6A3ALDH1A1NPSR1SMN1; SMN2
SCHEMBL3826078 0.65 SMN1; SMN2 (0.39) SLC6A3ALDH1A1NPSR1SMN1; SMN2
SCHEMBL4727041 0.65 PSEN1 (0.39) SLC6A3GAANPC1POLBRAB9A
Malonic Acid Diethyl Ester SCHEMBL8019960 0.65 GAA (0.47) GAAPOLBRAB9AALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007118844-A1 SUBSTITUTED PYRAZOLOPYRIMIDINES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR CONTROLLING HARMFUL FUNGI AND COMPOSITIONS COMPRISING THEM BASF SE (DE) 2007-10-25 WO disclosed